Search by Drug Name or NDC
NDC 00143-9141-10 Dobutamine 12.5 mg/mL Details
Dobutamine 12.5 mg/mL
Dobutamine is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is DOBUTAMINE HYDROCHLORIDE.
Product Information
NDC | 00143-9141 |
---|---|
Product ID | 0143-9141_06e5d151-bd26-4c5e-b84a-1a11a3147327 |
Associated GPIs | |
GCN Sequence Number | 064535 |
GCN Sequence Number Description | dobutamine HCl VIAL 250MG/20ML INTRAVEN |
HIC3 | A1C |
HIC3 Description | INOTROPIC DRUGS |
GCN | 14575 |
HICL Sequence Number | 000040 |
HICL Sequence Number Description | DOBUTAMINE HCL |
Brand/Generic | Generic |
Proprietary Name | Dobutamine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Dobutamine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 12.5 |
Active Ingredient Units | mg/mL |
Substance Name | DOBUTAMINE HYDROCHLORIDE |
Labeler Name | Hikma Pharmaceuticals USA Inc. |
Pharmaceutical Class | Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA074277 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00143-9141-10 (00143914110)
NDC Package Code | 0143-9141-10 |
---|---|
Billing NDC | 00143914110 |
Package | 10 VIAL in 1 CARTON (0143-9141-10) / 20 mL in 1 VIAL |
Marketing Start Date | 2023-05-03 |
NDC Exclude Flag | N |
Pricing Information | N/A |